Lower limb arteriopathy in diabetic patients;Artériopathie diabétique des membres inférieurs

EMC - Endocrinologie

Volumn 1, Issue 2, 2004, Pages 117-132

  Fredenrich, A ^a   Bouillanne, P J ^b   Batt, M ^b  

^a PASTEUR HOSPITAL   (France)

^b University Hospital of Nice University of Nice Sophia Antipolis   (France)

Author keywords

Arteriopathy; Atherosclerosis; Cardiovascular risk factor; Diabetes; Diabetic foot; Hyperglycemia; Hypertension; Lipids; Smoking

Indexed keywords

EID: 33645715493     PISSN: 17425653     EISSN: 17425653     Source Type: Journal    
DOI: 10.1016/j.emcend.2004.01.002     Document Type: Short Survey

References (44)

1. Adler AI, Stevens RJ, Neu A, Stratton IM, Boulton AJ, Holman RR. UKPDS 59: Hyperglycemia and other potentially modifiable risk factors for peripheral vascular disease in type 2 diabetes. Diabetes Care 2002;25:894-899.
2. Assal JP. Cost-effectiveness of diabetes education. Pharmacoeconomics 1995;8(suppl1):68-71.
3. Batt M, Ferrari E, Staccini P. Severity of tibioperoneal arterial disease: a marker for coronary artery disease. Int J Angiol 1998;7:97-101.
4. Benhamou AC, Dadon M, Emmerich J, Fontaine P, Got I, Guillausseau PJ, et al. Artériopathie des membres inférieurs chez le diabétique. Diabetes Métab 1997;23: 1-9.
5. Bolia A, Sayers RD, Thompson MM, Bell PR. Subintimal and intraluminal recanalization of occluded crural arteries by percutaneous balloon angioplasty. Eur J Vasc Surg 1994;8: 214-219.
6. Carpenter JP, Owen RS, Baum RA, Cope C, Barker CF, Berkowitz HD, et al. Magnetic resonance angiography of peripheral runoff vessels. J Vasc Surg 1992;16:807-815.
7. Carpentier B, Pradines S, Benhamou PY, Halimi S. Coûts de santé liés aux lésions des pieds chez les diabétiques dans les pays développés. Diabetes Métab 2000;26:75-80.
8. Cormier JM. Artériopathie oblitérante des membres de diabétique. Précis de diabétologie. Paris: Masson; 1977. p. 402-416.
9. Delcourt C, Papoz L. Le diabète et ses complications dans la population française. Paris: INSERM; 1996. p. 70-72.
10. Fredenrich A. Le cholestérol-LDL chez le diabétique. Médecine Thérapeutique Endocrinologie 2000;2:235-240.
11. Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, et al. Albuminuria and risk of coronary events, deaths and heart failure in diabetics and non diabetics individuals. JAMA 2001;286:421-426.
12. Grimaldi A, Heurtier A. Épidémiologie des complications cardiovasculaires du diabète. Diabetes Métab 1999; 25(suppl3):12-20.
13. Grimaldi A. Les lésions vasculaires des diabétiques. J Mal Vasc 2002;27:269-271.
14. Halimi S, Benhamou PY, Charras H. Le coût du pied diabétique. Diabetes Métab 1993;19(suppl5):518-522.
15. Hurley JJ, Auer AI, Hershey FB, Binnington HB, Woods Jr JJ, Nunnelee JD, et al. Distal arterial reconstruction: patency and limb salvage in diabetics. J Vasc Surg 1987;5:796-800.
16. JNC VI. The sixth report of the joint national committee on prevention, detection, evaluation and treatment of high blood pressure. Arch Intern Med 1997;157:2413-2446.
17. Katz MA, McCuskey P, Beggs JL, Johnson PC, Gaines JA. Relationships between micro vascular function and capillary structure in diabetic and non diabetic human skin. Diabetes 1989;38:1245-1250.
18. King GL, Brownlee MA. The cellular and molecular mechanisms of diabetic complications. Endocrinol Métab Clin North Am 1996;25:255-270.
19. Kumar S, Ashe HA, Parnell LN, Fernando DJS, Tsigos C, Young RJ, et al. The prevalence of foot ulcération and its correlates in type 2 diabetic patients: a population-based study. Diabet Med 1994;11:480-484.
20. Laakso M. Hypertension and macrovascular disease: the killing field of NIDDM. Diabetes Res Clin Pract 1998; 39(suppl):S27-S33.
21. Lofberg AM, Lorelius LE, Karacagil S, Westman B, Almgren B, Berqgvist D. The use of below-knee percutaneous transluminal angioplasty in arterial occlusive disease causing chronic critical limb ischemia. Cardiovasc Intervent Radial 1996;19:317-322.
22. Logerfo FW, Coffman JD. Vascular and microvascular disease of the foot in diabetes: implications for foot care. N Engl J Med 1984;311:1615-1619.
23. LoGerfo FW, Gibbons GW, Pomposelli Jr FB, Campbell DR, Miller A, Freeman DV, et al. Trends in the care of the diabetic foot: expanded role of arterial reconstruction. Arch Surg 1992;127:617-621.
24. Lopes-Virella MF, Klein RL, Virella G. Modification of lipoproteins in diabetes. Diabetes Metab Rev 1996;12:69-90.
25. Luizy F. Lésions à double étage: explorations, techniques et stratégies en chirurgie vasculaire. III. Paris: édition Cormier; 1997. p. 271-281.
26. Mellière D, Berrahal D, Desgranges P, Allaire E, Becquemin JP, Perlemuter L, et al. Influence of diabetes on revascularisation procedures of the aorta and lower limb arteries: early results. Eur J Vasc Endovasc Surg 1999;17: 438-441.
27. Mellière D, Berrahal D, D'Audiffret A, Desgranges P, Allaire E, Becquemin JP. Percutaneous transluminal angioplasty in patients with ischemic tissue necrosis is worthwhile. Cardiovasc Surg 2001;9:122-126.
28. Mogensen CE. Microalbuminuria, blood pressure, and diabetic renal disease: origin and development of ideas. Diabetotogia 1999;42:263-285.
29. Parfrey PS, Griffiths SM, Barrett BJ, Paul MD, Genge M, Withers J, et al. Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study. N Engl J Med 1989; 320:143-149.
30. Pomposelli Jr FB, Marcaccio EJ, Gibbons GW, Campbell DR, Freeman DV, Burgess AM, et al. Dorsalis pedis arterial bypass: durable limb salvage for foot ischemia in patients with diabetes mellitus. J Vasc Surg 1995;21:375-384.
31. Ricordeau P, Weill A, Bourrel R, Fender P, Allemand H. L'épidémiologie du diabète en France métropolitaine. Diabetes Métab 2000;26(suppl6):11-24.
32. Siperstein MD, Unger RH, Madison LL. Studies of muscle capillary basement membranes in normal subjects, diabetic and prediabetic patients. J Clin Invest 1968;47: 1973-1999.
33. Stamler J, Vaccaro O, Neaton JD, Wenworth D. Diabetes, other risk factors, and 12-year cardio-vascular mortality for men screened in the multiple risk factor intervention trial. Diabetes Care 1993;16:434-444.
34. Steinbrecher UP, Witztum JL. Glycosylation of low density lipoproteins to an extent comparable to that seen in diabetes slows their catabolism. Diabetes 1984;33:130-134.
35. Suivi du patient diabétique de type 2 à l'exclusion du suivi des complications. Diabetes Métab 1999;25(suppl2):19-79 Recommandations de l'Agence Nationale d'Accréditation et d'Évaluation en Santé (ANAES).
36. Taylor LM, Porter JM. The clinical course of diabetics extra require emergent foot surgery because of infection or ischemia. J Vasc Surg 1987;6:454-459.
37. United Kingdom Prospective Diabetes Study (UKPDS) group. Intensive blood glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-853.
38. United Kingdom Prospective Diabetes Study (UKPDS) group. Risk factors for coronary disease in NIDDM (UKPDS 23). Br Med J 1998;316:823-828.
39. United Kingdom Prospective Diabetes Study (UKPDS) group. Tight blood pressure control and risk of macrovascular complications in type 2 diabetes (UKPDS 38). Br Med J 1998;317:703-713.
40. Vayssairat M. Explorations microcirculatoires. J Mal Vasc 2002;27:280.
41. Verges B. Dyslipidaemia in diabetes mellitus. Diabetes Métab 1998;25(suppl3):32-40.
42. Verhelst R. Pontages distaux: quelles indications et quels résultats? J Mal Vasc 2002;27:293-297.
43. Vlassara H. Recent progress in advanced glycosylation end products and diabetic complications. Diabetes 1997;46: 519-525.
44. Wolfle KD, Bruijnen H, Loeprecht H, Rumenapf G, Schweiger H, Grabitz K, et al. Graft patency and clinical outcome of femoro distal arterial reconstruction in diabetic and non-diabetic patients: results of a multicentre comparative analysis. Eur J Vasc Endovasc Surg 2003;25:229-234.